In the News

Recent Coverage of HMS in the News
October 24, 2012

Aspirin, one of the world’s oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that’s thought to play a role in the disease. Among patients with the mutations, those who regularly took aspirin lived longer than those who didn’t, a major study found. Andrew Chan, HMS associate professor of medicine at Massachusetts General Hospital, led the study.

October 24, 2012

A patient’s genetic makeup may explain the “placebo effect,” in which people perceive that a fake treatment makes them feel better, according to a study that may help researchers design better clinical trials. Kathryn Hall, HMS research fellow in medicine at Beth Israel Deaconess Medical Center, is the lead author. Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, is also an author of the study.

October 24, 2012

A majority of patients with advanced lung and colorectal cancer harbor the fundamental misperception that treatments that can extend life and alleviate pain might also cure them, according to a new study. Jane Weeks, HMS professor of medicine at Dana-Farber Cancer Institute, led the team. Deborah Schrag, HMS associate professor of medicine at Dana-Farber Cancer Institute, is a co-author. David Ryan, HMS associate professor of medicine at Massachusetts General Hospital, is also quoted.

October 24, 2012

Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014. Alvaro Pascual-Leone, HMS professor of neurology at Beth Israel Deaconess Medical Center, is leading a trial of the system.

October 23, 2012

Ravi Parikh, a fourth-year student at HMS, was a guest on Radio Boston to discuss Question 2, the Mass. ballot question about physician-assisted suicide.

October 22, 2012

Seventy-five Massachusetts doctors, hospital facilities, eye clinics, and rehabilitation centers received drugs in recent months produced by the New England Compounding Center, the Framingham pharmacy under investigation for producing tainted injections linked to nearly 300 cases of fungal meningitis in 16 states, and 23 deaths, the US Food and Drug Administration said. Several HMS-affiliated hospitals are on the list.

October 22, 2012

Knee replacement surgeries are skyrocketing. A new study highlights the role of communication and shared decision-making between doctors and patients in determining who gets knee replacements and other elective procedures. Elena Losina, HMS associate professor of orthopedic surgery and Jeffrey Katz, HMS professor of medicine, both of Brigham and Women’s Hospital; and Karen Sepucha, HMS assistant professor of medicine at Massachusetts General Hospital, are quoted.

October 21, 2012

Recent high-profile cases of mass shootings have renewed a vigorous debate about the causes of violent behavior. Judith G. Edersheim, HMS assistant clinical professor of psychiatry; Bruce H. Price, HMS associate professor of neurology; and Jordan W. Smoller, HMS associate professor of psychiatry, all of Massachusetts General Hospital, authored the piece.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.